연구동향 분석

Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic Treatment

Mehmet Güneş Mehmet Akif Camkurt Mahmut Bulut Süleyman Demir Aslıhan Okan İbiloğlu Mehmet Cemal Kaya Abdullah Atlı İbrahim Kaplan Aytekin Sir 2016년

논문상세정보
인용/피인용

' Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic Treatment' 의 참고문헌

  • Understanding Schizophrenia as a Disorder of Consciousness: Biological Correlates and Translational Implications from Quantum Theory Perspectives
    Ganesan Venkatasubramanian Clinical Psychopharmacology and Neuroscience 13 1 36-47 [2015]
  • The three-gene paraoxonase family:physiologic roles, actions and regulation
    Précourt LP Atherosclerosis 214 20-36 [2011]
  • The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance
    Akyol O Prog Neuropsychopharmacol Biol Psychiatry 26 995-1005 [2002]
  • The human serum paraoxonase/arylesterase polymorphism
    Eckerson HW Am J Hum Genet 35 1126-1138 [1983]
  • The Relationship between Language Ability and Cognitive Function in Patients with Schizophrenia
    김성진 Clinical Psychopharmacology and Neuroscience 13 3 288-295 [2015]
  • Smoking habits and plasma lipid peroxide and vitamin E levels in never-treated first-episode patients with schizophrenia
    Scottish Schizophrenia Research Group Br J Psychiatry 176 290-293 [2000]
  • Serum paraoxonase activities in hemodialyzed uremic patients: cohort study
    Juretić D Croat Med J 42 146-150 [2001]
  • Regulation of Interleukin-6 and Leptin in Schizophrenia Patients: A Preliminary Analysis
    Sasi Neelamekam Clinical Psychopharmacology and Neuroscience 12 3 209-214 [2014]
  • Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
    Unsal C Neuropsychiatr Dis Treat 9 1545-1552 [2013]
  • Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities
    Gan KN Drug Metab Dispos 19 100-106 [1991]
  • Protective effects of atypical antipsychotic drugs against MPP(+)-induced oxidative stress in PC12 cells
    Park SW Neurosci Res 69 283-290 [2011]
  • Oxidative stress in drug naïve first episode psychosis and antioxidant effects of risperidone
    Noto C J Psychiatr Res 68 210-216 [2015]
  • Oxidative imbalance in obsessive compulsive disorder patients: a total evaluation of oxidant-antioxidant status
    Selek S Prog Neuropsychopharmacol Biol Psychiatry 32 487-491 [2008]
  • Neuroimmunological Aberrations and Cerebral Asymmetry Abnormalities in Schizophrenia: Select Perspectives on Pathogenesis
    Ganesan Venkatasubramanian Clinical Psychopharmacology and Neuroscience 12 1 8-18 [2014]
  • Malondialdehyde levels in adult attentiondeficit hyperactivity disorder
    Bulut M J Psychiatry Neurosci 32 435-438 [2007]
  • Investigation of Dysregulation of Several MicroRNAs in Peripheral Blood of Schizophrenia Patients
    Mehmet Akif Camkurt Clinical Psychopharmacology and Neuroscience 14 3 256-260 [2016]
  • Human serum paraoxonase
    Mackness B Gen Pharmacol 31 329-336 [1998]
  • Holistic Consideration of Patients with Schizophrenia to Improve Medication Adherence and Outcomes
    Lan-Ting Lee Clinical Psychopharmacology and Neuroscience 13 2 138-143 [2015]
  • Haloperidolinduced cell death--mechanism and protection with vitamin E in vitro
    Behl C Neuroreport 7 360-364 [1995]
  • Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia
    Herken H Mol Psychiatry 6 66-73 [2001]
  • Evaluation of malondialdehyde, superoxide dismutase and catalase activity and their diagnostic value in drug naïve, first episode, non-smoker major depression patients and healthy controls
    Camkurt MA Psychiatr Res 238 81-85 [2016]
  • Effect of Polymorphisms of Three Genes Mediating Monoamine Signalling on Brain Morphometry in Schizophrenia and Healthy Subjects
    Anupa A. Vijayakumari Clinical Psychopharmacology and Neuroscience 13 1 68-82 [2015]
  • Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain
    Parikh V J Psychiatr Res 37 43-51 [2003]
  • Diagnostic performance of increased prolidase activity in schizophrenia
    Güneş M Neurosci Lett 613 36-40 [2016]
  • Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment
    Sarandol A J Psychopharmacol 21 857-863 [2007]
  • Comparison of plasma MicroRNA levels in drug naive, first episode depressed patients and healthy controls
    Camkurt MA J Psychiatr Res 69 67-71 [2015]
  • Cinkilinc N. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder
    Kuloglu M Cell Biochem Funct 20 171-175 [2002]
  • Association of thalamic serotonin transporter and interleukin-10 in bipolar I disorder: a SPECT study
    Hsu JW Bipolar Disord 16 241-248 [2014]
  • Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations
    Grignon S Prog Neuropsychopharmacol Biol Psychiatry 31 365-369 [2007]
  • Antipsychotic Prescribing Patterns in First-episode Schizophrenia: A Five-year Comparison
    노대영 Clinical Psychopharmacology and Neuroscience 13 3 275-282 [2015]
  • Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation
    Mackness MI Lancet 349 851-852 [1997]
  • A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials
    Draper HH Free Radic Biol Med 15 353-363 [1993]